MedTrace Logo

Decorin in Sub Scleral Trabeculectomy

NCT03924544 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2019-04-23

No results posted yet for this study

Summary

This is a prospective, single-center, interventional, randomized controlled study comparing Decorin as antifibrotic agent in sub scleral trabeculectomy versus Mitomycin.

Conditions

  • Primary Open-angle Glaucoma

Interventions

DRUG

Decorin

Antifibrotic agent

DRUG

Mitomycin c

Antifibrotic agent

Sponsors & Collaborators

  • University of Luebeck

    collaborator OTHER

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-09-01
Completion
2022-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03924544 on ClinicalTrials.gov